Postmenopausal Women

Reproductive·MeSH: Motor Activity

14 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(9)

Drug	Company
afinitor	Novartis AG (NVS)
alendronate	Mylan II B.V. (MYL)
everolimus	Mylan II B.V. (MYL)
Forteo®	ELI LILLY & Co (LLY)
progesterone	DR REDDYS LABORATORIES LTD (RDY)
teriparatide	Amphastar Pharmaceuticals, Inc. (AMPH)
tykerb	Novartis AG (NVS)
tymlos	Radius Health, Inc. (RDUS)
xgeva	AMGEN INC (AMGN)

Phase 3(1)

Drug	Company
abaloparatide-td	Radius Health, Inc. (RDUS)

Phase 1(2)

Drug	Company
KSHN001034	Crinetics Pharmaceuticals, Inc. (CRNX)
kshn001126	Amneal Pharmaceuticals, Inc. (AMRX)

Unknown(2)

Drug	Company
Femoston™	ABBOTT LABORATORIES (ABT)
HLX14	Organon & Co. (OGN)

BioSniper tracks 14 drugs in development for Postmenopausal Women across 11 companies.

There are 1 clinical trial targeting Postmenopausal Women tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.